Nobilis® MG INAC

NOBILIS^® MG Inac

Reg. No. G2695 (Act 36/1947)

Namibia Reg. No. V05/24.3/58 [NS0]

INDICATIONS

Nobilis^® MG Inac is an inactivated vaccine for the immunisation of chickens as an aid in the prevention of clinical signs and egg production losses caused by Mycoplasma gallisepticum infection.

COMPOSITION

Nobilis^® MG Inac contains Mycoplasma gallisepticum organisms, strain 6/85, inactivated by thiomersal and suspended in the aqueous phase of a water-in-oil emulsion in order to enhance the stimulation of immunity.

CONTENTS

Each 0,5 mℓ dose of Nobilis^® MG Inac contains at least 0,23 O.D. units (one chicken effective dose) of Mycoplasma gallisepticum cells.

STORAGE

• Store in the dark between 2 °C and 8 °C.
• Do not freeze.
• Protect from exposure to direct sunlight.
• Allow the vaccine to gradually reach room temperature (20 ºC to 25 ºC) before use.
• Avoid prolonged or repetitive exposure to high ambient temperatures following withdrawal from the refrigerator prior to use.

WARNINGS

• Withdrawal period: Do not market chickens for slaughter purposes for at least 6 weeks after vaccination. Ensure that chickens marketed do not have swellings at the vaccination site, as this may result in the condemnation of the chickens.
• Avoid intravenous injection.
• Vaccinate only healthy chickens.
• Vaccination of chickens in production may lead to a slight decrease in egg production.
• Accidental self-injection may lead to severe local allergic reaction. Consult a physician immediately informing him/her that the vaccine contains a mineral oil.
• Do not store partially used containers for future use, and use entire contents once opened.
• Opened bottles should be used within 3 hours.
• Dispose of any unused, reconstituted vaccine, empty vials, needle etc. in accordance with local waste disposal regulations after completion of vaccination.
• KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
• Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

• Observe aseptic precautions. Ensure that vaccination equipment (needles, syringes, etc.) is clean and sterile before use.
• Ensure that all equipment is kept clean and sterile during vaccination.
• Do not mix the vaccine with other vaccines.
• It is good vaccination practice when handling the vaccine to avoid contact with the eyes, hands and clothing.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

RECOMMENDED VACCINATION PROGRAMME

• Chickens may be vaccinated from 3 weeks old and older.
• Do not vaccinate within 14 days before the onset of lay or during lay.

DOSAGE AND ADMINISTRATION

• Allow the vaccine to gradually reach room temperature (20 °C to 25 °C) prior to use.
• Remove the aluminium overseal and the vaccine is ready for use.
• Shake the bottle prior to and at regular intervals during the vaccination process.
• Inject 0,5 mℓ per chicken subcutaneously into the lower part of the back of the neck.
• Inject all the chickens in the flock.
• Use a sterilised syringe and needle.

VACCINATION REACTIONS

In healthy chickens no clinical reaction will be observed. For some weeks after vaccination a slight swelling may be felt at the site of the vaccination. Local tissue reactions may occur.

PRESENTATION

500 mℓ, Type III glass vial or a PET-flask closed with a nitryl rubber stopper and sealed with a coded aluminium cap.

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

25 October 1999